Performance
All

1.30%2026
2026
30.71%2025
2025
7.50%2024
2024
30.7%0%-30.7%
neculaucatalin
End of 2025: A year of discipline and results beyond expectations in the financial markets 📈 The year 2025 ends with a balance sheet that confirms to me, once again, that experience and long-term strategy are the most valuable assets of an investor. After more than 1,800 accumulated trading days (over... Show More

About neculaucatalin

This investor has not filled out their bio.
0 Copiers
6 Followers